Player FM - Internet Radio Done Right
79 subscribers
Checked 3M ago
تمت الإضافة منذ قبل seven عام
المحتوى المقدم من Audioboom and Pharmaceutical Executive Podcast. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Audioboom and Pharmaceutical Executive Podcast أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
<
<div class="span index">1</div> <span><a class="" data-remote="true" data-type="html" href="/series/series-3594218">The Innovators & Investors Podcast</a></span>


The Innovators & Investors Podcast: Connecting the Startup Ecosystem. We are on a mission to bridge the gap between founders, investors, and industry leaders across the early-stage ecosystem. By bringing together visionaries from cutting-edge startups, venture capitalists, family offices, angel investors, accelerators, and studios, we offer a platform for sharing invaluable insights, market trends, and first-hand experiences. Whether you’re an entrepreneur navigating the challenges of building a business or an investor seeking opportunities in emerging technologies, our podcast provides a front-row seat to the dynamic world of innovation and investment. Tune in to gain a comprehensive understanding of the startup landscape, stay ahead of the curve, and benefit from the collective wisdom of those shaping the future. Think you'd be a great guest on the show? Apply at https://finstratmgmt.com/innovators-investors-podcast/
Pharmaceutical Executive
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 2084987
المحتوى المقدم من Audioboom and Pharmaceutical Executive Podcast. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Audioboom and Pharmaceutical Executive Podcast أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
…
continue reading
179 حلقات
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 2084987
المحتوى المقدم من Audioboom and Pharmaceutical Executive Podcast. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Audioboom and Pharmaceutical Executive Podcast أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
…
continue reading
179 حلقات
كل الحلقات
×P
Pharmaceutical Executive

1 Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research 17:26
17:26
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:26
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis trials. She also talks about Takeda's partnerships with community stakeholders like Inside Edge, Black Health Matters, and Hispanic Communication Global Network to help improve engagement, address operational barriers by incorporating multicultural imagery, and prioritize sites with diverse patient demographics. She also explains how they've enhanced investigator diversity through educational sessions and multilingual toolkits, and how Takeda aims to expand these efforts globally.…
P
Pharmaceutical Executive

1 Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals 17:36
17:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:36
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses: The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts. How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts The importance of telehealth in ensuring medication availability Strategic partnerships between digital health platforms and pharma companies to improve patient care and access and more…
P
Pharmaceutical Executive

1 The Misinformation Maze: Navigating Public Health in the Digital Age 24:22
24:22
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:22
In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses: The threat of misinformation to public health and how emotional appeal plays a part Where patients are turning for trustworthy health information Strategies that can be used to verify information Pharma's role in helping to ensure patients have access to health insights they can trust Why the industry is turning to peer-to-patient platforms, trusted patient communities, and pharmacies to educate patients What kind of role regulatory agencies should play in the battle against misinformation and much more! Check out our new look and read our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025…
P
Pharmaceutical Executive

1 Navigating Distrust: Pharma in the Age of Social Media 26:45
26:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب26:45
In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss: The growing distrust in social media Why people trust friends and influencers over companies The EMA's departure from X Concerns about information accessibility The healthcare industry's trust gap "Dark Social" and SO MUCH MORE! Pharmaceutical Executive has a brand new look! Click through our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025…
P
Pharmaceutical Executive

1 Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement 19:23
19:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب19:23
In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence. By utilizing patient-level data and predictive modeling, AI can identify individual needs and preferences, tailoring interventions to optimize treatment outcomes. This personalized approach addresses the common challenges of medication non-adherence and improves patient outcomes. The discussion highlights the importance of ethical considerations and data privacy when leveraging AI in healthcare. By focusing on patient well-being and using AI responsibly, healthcare providers can significantly enhance patient experiences and improve overall health outcomes.…
P
Pharmaceutical Executive

1 The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations 30:12
30:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب30:12
In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility ( @md.lawrence.werlin on TikTok ), discusses the challenges of addressing fertility misinformation on social media. He emphasizes the importance of providing accurate and reliable information and encourages patients to consult with healthcare professionals. He also discusses the ethical considerations of using social media to share personal and professional experiences in the field of fertility and so much more!…
P
Pharmaceutical Executive

1 Key Findings of the NIAGARA and HIMALAYA Trials 13:20
13:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:20
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.…
P
Pharmaceutical Executive

1 Fake Weight Loss Drugs: Growing Threat to Consumer Health 21:15
21:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:15
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss: Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks What can be done to raise awareness among consumers about the dangers of counterfeit medications Ways increase access to legitimate weight loss medications, especially for those in underserved communities and much more!…
P
Pharmaceutical Executive

1 A Different Approach to Dermatology Care 14:52
14:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:52
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.
P
Pharmaceutical Executive

1 Beyond the Birthrate: The Societal Costs of Maternal Morality 15:48
15:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب15:48
In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses: The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical areas of need in maternal health How her in-practice experience as an OB-GYN are informing Organon's strategic approach to addressing maternal health challenges and more!…
P
Pharmaceutical Executive

Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of both large and independent pharmacies, what alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities), some potential long term consequences if these pharmacy closures continue, and so much more…
P
Pharmaceutical Executive

1 The Weight-Loss Gold Rush: Legal and Regulatory Implications 17:10
17:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:10
Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses: Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs What needs to be done for GLP-1s to be covered Steps companies developing weight-loss medications should take to ensure responsible and ethical practice Advice for investors and financiers who are considering entering the weight-loss medication market…
P
Pharmaceutical Executive

1 Healthcare Marketing Strategies for Reaching Diverse Audiences 13:10
13:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:10
Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more. Link to Honeycomb Health video: https://www.pharmexec.com/view/going-beyond-visuals-to-connect-with-diverse-audiences…
P
Pharmaceutical Executive

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.
P
Pharmaceutical Executive

1 Fierce Females in the Life Science Space 16:18
16:18
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب16:18
In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands. Featured in this episode are: Emma Banks, CEO, ramarketing Jill Jaroch, Senior Director, Women’s Health & Urology Marketing, Astellas Marie Teil, Global Head, UCB’s Women of Childbearing Age Program Julia Lakeland, Chief Product Office, uMotif If you enjoyed this episode of our podcast, we encourage you to seek out the longer version of each of these videos—Linked on our website!…
P
Pharmaceutical Executive

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses their recent data and research about some massive behavioral shifts occurring across Gen-Z, and how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract the ever elusive generation.
P
Pharmaceutical Executive

1 Recent Licensing Agreement Poised to Advance Company ADC 22:51
22:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب22:51
Jingsong Wang, Chairman of Nona Biosciences, discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033, an innovative antibody-drug conjugate (ADC) targeting MSLN, a key antigen in various solid tumors. Wang believes that the partnership will significantly advance Nona's Harbour Mice® platform and ADC ecosystem.…
P
Pharmaceutical Executive

Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.…
P
Pharmaceutical Executive

1 Reshaping Pharmacovigilance in the age of AI 17:00
17:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:00
Sameer Lal, Sr. Vice President, Enterprise Medical Solutions at Indegene, discusses findings from their new study about Reshaping Pharmacovigilance in the age of AI, digital/generative AI opportunities, how quickly the industry is adopting this technology, and much more.
P
Pharmaceutical Executive

Dr. Julien Boisdron, Global Head of OneMedical / Chief Medical Officer Roche Diabetes Care, discusses the current standard for diabetes care, the importance of patient advocacy and mental health, what the future of this space holds, and much more.
P
Pharmaceutical Executive

1 DCT Opportunities in Clinical Research 28:42
28:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب28:42
Edward Triebell, Commercial Executive Director for MRN Technologies, discusses the biggest digital trends in clinical research right now, how COVID-19 impacted the use of digital within sponsors and CROs, what the future of DCT services looks like, and much more.
P
Pharmaceutical Executive

1 New FDA SaMD Guidance Will Bring Monumental Changes to Industry 10:31
10:31
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب10:31
David Klein, co founder and CEO of Click Therapeutics, discusses the new FDA SaMD guidance, the clear differences between companion apps and SaMD, and gives insight into what to expect from this combination in the future.
P
Pharmaceutical Executive

1 Venture Creation Firm Reveals Strategies For Launching New Companies & Forming Collaborations 37:47
37:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب37:47
In this exclusive Pharm Exec Podcast episode with Paul Biondi, executive partner at Flagship Pioneering (the venture creation firm behind Moderna and many other life science firms) and president of Pioneering Medicines, Meg Rivers, managing editor, asks Biondi about 1) the process of founding a company; 2) what factors they consider when deciding whether to partner with a pharmaceutical company (like your partnership with Novo Nordisk) or a foundation (like your partnership with the Cystic Fibrosis Foundation)—along with what makes one organization stand out from another; 3) where science is booming in pharma right now; 4) deciding whether to found a company looking to launch innovations in an existing space vs. pursue innovations in an untapped space; and 5) signs that a company will achieve commercial success from early on.…
P
Pharmaceutical Executive

1 Avoiding Commercialization Pitfalls for CGTs 31:18
31:18
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب31:18
Commercialization is a tough road to navigate even for the most established bio/pharmaceutical therapies. But as cell and gene therapies (CGTs) continue to form roots and make a splash worldwide—but specifically in the US—commercialization forms its own version of standardization and best practices. In this exclusive interview with Pharmaceutical Executive, Lung-I Cheng, vice president of CGT, Cencora (formerly AmerisourceBergen), discusses: 1) defining CGT commercialization strategies and foundational knowledge—and the best music metaphor 2) what he wishes companies knew about commercialization strategies 3) common knowledge gaps of CGTs 4) how CGT developers can overcome key challenges, including those related to patient access, regulatory requirements, and market access 5) how planning for allogeneic cell therapies differs from autologous cell therapies and gene therapies 6) how companies can demonstrate CGT value as more products enter the development pipeline (and competition intensifies) 7) when to start planning a CGT commercialization strategy 8) predictions for the CGT market in five years…
P
Pharmaceutical Executive

Gerald Kierce, co founder and CEO of Trustible and Andrew Gamino-Cheong, the company's CTO and co founder, delve into the realm of artificial intelligence discussing Trustible's mission and its pioneering efforts to ensure ethical AI use particularly in the pharmaceutical industry, and how it navigates complex AI regulations across the globe.…
P
Pharmaceutical Executive

1 Drug Pricing Challenges and Navigating The IRA 39:08
39:08
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب39:08
How to price a bio/pharmaceutical drug is one of the most complex topics for pharmaceutical executives, as there are many factors to consider. Alice Valder Curran, life sciences regulatory expert and partner, Hogan Lovells LLP, reveals the following to Pharmaceutical Executive® in this exclusive Pharm Exec Podcast interview: 1) the biggest drug pricing challenges today; 2) current efforts to lower drug pricing; 3) what companies should consider as it relates to drug pricing from a legal perspective; 3) the status of the Inflation Reduction Act (IRA), specifically what should companies be watching for; 4) potential impact on companies from the IRA; 5) IRA milestones we will be seeing through the end of the year; and 6) drug pricing recommendations (from a legal perspective). ACT podcast: https://www.appliedclinicaltrialsonline.com/editorial-podcasts…
P
Pharmaceutical Executive

1 Pharma Marketing in the Age of AI: A New Era Begins 39:27
39:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب39:27
In this podcast, Sharlene Jenner, vice president of engagement strategy at Abelson Taylor and professor of AI and personalization for digital marketers at Southern Methodist University, leads a panel of five industry leaders in a roundtable discussion. The conversation delves into the practicalities of current AI applications and confronts the ethical and regulatory issues related to the technology. The panelists also explore the direct consequences and prospective implications of AI, providing listeners with a snapshot of the present and an outlook on the transformative potential of emerging technologies in the pharmaceutical marketing sphere. The panel consists of: Faruk Capan, chief innovation officer, EVERSANA, and CEO, EVERSANA INTOUCH; Anurag Banerjee, CEO and founder, Quilt.AI ; Jeff Headd, vice president, commercial data science, The Janssen Pharmaceutical Companies of Johnson & Johnson; and Stephen Onikoro, senior principal, head of strategy, PharmaForceIQ. Sponsored by: ZS https://www.zs.com/…
P
Pharmaceutical Executive

1 Transforming Cancer Care: Data, AI, and Patient-Centered Care 31:36
31:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب31:36
In this podcast, Mohit Manrao, the SVP and head of US oncology at AstraZeneca, shares his journey from growing up in Northern India with aspirations of becoming a doctor, to leading oncology initiatives at AstraZeneca in the US. A central strategy to ultimately eliminate cancer includes ensuring that the latest scientific advancements are accessible to patients in every zip code and the necessity of integrating the patient perspective at every stage—from early discovery to commercialization, recognizing the importance of diverse patient needs, non-invasive diagnostics, and alleviating challenges in access to screenings and treatments.…
P
Pharmaceutical Executive

1 AI Frontiers: Navigating the Risks, Rewards, and Regulations 30:12
30:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب30:12
Welcome to a riveting episode of the Pharm Exec podcast, where we dive headfirst into the transformative world of AI in healthcare with Sharlene Jenner, vice president of engagement strategy with the award-winning agency Abelson Taylor. This enlightening conversation traverses the advancements and potential risks of AI, the revolution it is stirring in pharmaceutical marketing, and its game-changing role in understanding complex protein structures. Amid the rapid innovation, we explore the urgent need for ethical guidelines and regulations to keep pace with technology.…
P
Pharmaceutical Executive

1 Listening is the Key to Good Leadership 34:05
34:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب34:05
We all know that the pharma industry is about people—bettering the lives of others through good research, life-changing pharmaceuticals, and keeping the patient front and center. But Jag Dosanjh, president, US neuroscience and eye care, AbbVie, lives that principle. In this podcast episode, Meg Rivers, managing editor, talks with Dosanjh about what he calls a “people business” and his approach to leadership. He starts his career in the medical sales space before working in many different roles and therapeutic areas before ultimately landing at AbbVie. He was also nominated HBA’s mentor of the year and shares insights into being a good leader and mentor. One of his tips was: “If you listen well, you can learn well.” In addition, he emphasized the importance of curiosity, learning, and the pursuit of a smile.…
P
Pharmaceutical Executive

1 The Trust Imperative: Defining and Building Trust in Pharma 14:30
14:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:30
This Pharma 50 companion episode delves into the vital topic of trust within the pharmaceutical industry. Morton Nielsen, senior partner for the life sciences practice at Wittkieffer, dissects the concept, drawing on parallels to Maslow's hierarchy of needs, and discusses practical methods for measuring and operationally improving trust. This episode is a must-listen for those interested in understanding the current state and future evolution of trust in the pharmaceutical sector, an industry where trust forms a fundamental pillar for delivering on its mission statement. Read the 2023 Pharma 50 article here: https://www.pharmexec.com/view/2023-pharm-exec-top-50-companies…
P
Pharmaceutical Executive

1 Emerging Potential: Changing Lives One Story, One Therapeutic at a Time 50:43
50:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب50:43
The 2023 Emerging Pharma Leaders share with Meg Rivers, managing editor of Pharmaceutical Executive, and the editorial team what makes a good leader, what has made them the proudest in their career, lessons they wish they had known when starting out, and more. Congratulations to the 2023 Emerging Pharma Leaders: Natasha A. Hernday, chief business officer, Seagen; Simon Holland, vice president, women's health commercial lead, Organon; Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio; Frank Watanabe, president and CEO, Arcutis Biotherapeutics; and Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics. SPONSOR: APEX Awards https://www.pharmexec.com/apex-awards…
P
Pharmaceutical Executive

1 Drug Approvals And Launches From A Legal Perspective 34:05
34:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب34:05
Launching a drug and receiving approvals—whether it’s in the U.S. or globally—is challenging to navigate. It’s a process that often takes years and a lot of back-and-forth communication with regulatory bodies. In this episode, Torrey Cope, partner, food, drug, and medical device practice, Sidley Austin LLP, discusses drug approvals and drug launches from a legal perspective, including 1) his work as an attorney; 2) tips for drug approvals from a legal perspective; 3) current regulatory challenges the industry is facing in the U.S.; 4) the shift away from a one-sized-fits all approach to marketing and global launches; 5) tips for companies navigating the regulatory landscape in the U.S.; 6) when to launch a drug in a country outside of the U.S.; and 7) drug pricing. Join Meg Rivers, managing editor, as she dives into this topic with Cope.…
P
Pharmaceutical Executive

1 Exploring Arcutis’s Patient - Centric Dermatology Innovations 23:18
23:18
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:18
In this episode of the Pharmaceutical Executive Podcast, we dive into a conversation with Frank Watanabe, president and CEO of Arcutis, a medical dermatology company with a patient-first approach. Discover how Arcutis is transforming the dermatology landscape with its innovative product offerings, such as FDA-approved Zoryve for topical treatment of plaque psoriasis and their upcoming products for seborrheic dermatitis and atopic dermatitis. Learn about the company's guiding principles, the importance of keeping patients at the forefront of decision-making, and the need for further innovation in the dermatology sector after decades of stagnation.…
P
Pharmaceutical Executive

1 Tackling Reproductive Health And Fertility Care 41:32
41:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب41:32
Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, speaks with Meg Rivers, managing editor, about: 1) her journey into the world of pharma, including her transition from being a physician/surgeon to working in clinical trials; 2) both women’s and men’s reproductive health; 3) the latest technologies in fertility treatment (for men and women); 4) unmet needs in fertility care; 5) trends in contraception and fertility treatment; 6) DE&I and access to care, and 7) predictions for the contraception and fertility treatment spaces in the coming years…
P
Pharmaceutical Executive

1 Repurposing Drugs - How One Doctor Saved His Own Life And Hopes To Save Others 27:11
27:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب27:11
Two companies join forces to unlock the hidden potential in existing drugs to save lives suffering from rare diseases. In 2010, Dr. David Fajgenbaum, co-founder, Every Cure, was a third-year medical student when he became critically ill with Castleman disease (CD). After months of hospitalization and in critical condition, nearly dying several times, he launched an initiative to find treatments to save his life and others. Fajgenbaum and Michelle Longmire, CEO and co-founder, Medable—both physicians and entrepreneurs—team up in a new partnership to treat rare diseases by repurposing drugs that are already on the market and finding other therapeutic areas where these drugs can have an impact.…
P
Pharmaceutical Executive

1 Tearing Down Silos to Usher Innovative Medicines to Patients Faster 22:00
22:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب22:00
Cathi Ahearn is a seasoned biotechnology leaders with formative stints at Genentech, Roche, and now at Bristol Myers Squibb, as SVP of worldwide commercial portfolio strategy. Cathi is focused on one goal: shortening the path between creating medical innovation and getting that innovation to patients. Cathi chats with senior editor at Pharmaceutical Executive about her experiences in the past 20+ years and most importantly, the power of cross-functional collaboration, bringing different teams together and tearing down silos that limit the impact new innovations can have for patients.…
P
Pharmaceutical Executive

Across most industries, finding and keeping the right talent is a constant challenge for companies. This challenge is perhaps even more prevalent in the pharmaceutical industry, which requires a significant amount of specialization. Rebekah Martin, senior VP of reward, inclusion, and talent acquisition for AstraZeneca, discusses recruiting talent in pharma with Meg Rivers, managing editor. Specifically, Martin talks about 1) her journey into pharma; 2) reasons that finding and keeping talent is a challenge today in pharma; 3) ways to address the need for talent; 4) identifying and nurturing young talent; 5) increasing interest in working in bio/pharma, particularly among students; 6) how talent can be nurtured; and 7)how the industry can support and encourage diversity in the workforce.…
P
Pharmaceutical Executive

1 Behind the Creative: Let’s Hear from the Creators 19:51
19:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب19:51
Join Tina Fascetti, CCO of The Agency Network at MJH Life Sciences for a podcast interview with Ryan Potter, ACD Art, and Priscila Ramos, ACD Copy, from McCann Health as they share the "behind the creative" story of their Apex Award-winning consumer creative campaign for Entresto. The Apex Awards is judged by none other than the people they are aimed to connect with, the patients themselves.…
P
Pharmaceutical Executive

1 The Explosive Arrival of Chat GPT and Generative AI 22:04
22:04
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب22:04
In his position, Faruk Capan leads thousands of employees around the globe with a focus on bold innovation—one can imagine how excited he is about Chat GPT, which set the record for fastest-growing user base in history. Senior editor Fran Pollaro and Faruk go back and forth about positives, negatives, hopes, and fears attached to generative AI for us as regular humans, and as pharma marketers. The pair delve into content creation, creative, video production, research, sales and marketing…it’s clear that we’re on the precipice of life-changing innovation.…
P
Pharmaceutical Executive

It is no easy feat to break into a male-dominated field as a woman, no less the bio/pharmaceutical industry. Piper Trelstad, PhD, head of chemistry, manufacturing, and control (CMC), Bill & Melinda Gates Medical Research Institute, shares with Meg Rivers, editor-in-chief of Pharmaceutical Executive, her experiences working in the industry, specifically in the vaccines space, as well as what it was like for her moving up the ranks as a woman. Other topics discussed include Trelstad’s predictions for more women working at the C-suite level, the inner workings of the Bill & Melinda Gates Medical Research Institute (including work on an infant probiotic), insight into her personal journey, and more.…
P
Pharmaceutical Executive

1 Let’s Get Social: The Ascendancy of Social Media to the Top of the Media Mix 19:20
19:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب19:20
Amanda Powers-Han, chief marketing officer at Greater Than One, has a couple of decades in the industry and is always on top of the latest trends in marketing and media for the pharma industry. She talks with senior editor Fran Pollaro about the ascension of social media as an incremental investment to one that is foundational. The pair delve into the honed focus on HCPs, especially in the rare disease space, building out sophisticated targeting strategies via multiple data partners, and the different uses across the social landscape, especially with video—from HCP social sites like Dermo and Medscape to the topical Twitter and its recognized peers like TikTok, Facebook, LinkedIn, and YouTube.…
P
Pharmaceutical Executive

1 Gene Therapies: 2023 Predictions and Commercialization Challenges 23:05
23:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:05
Cell and gene therapies are at the tip of everyone’s tongues in biopharma. Significant headway has been made in this space, though there is more research that needs to be done and many more therapeutic areas to eventually apply this method of treatment to. Chris Fox, president of Novartis Gene Therapies, shares insights into her work with gene therapies and discusses commercialization challenges. Through its gene therapies business, Novartis builds on the capabilities created through its experience with Zolgensma, a gene therapy for spinal muscular atrophy. Fox also dives into how she entered the pharma space, her role at Novartis, balancing work and home life, and what the Novartis team is most proud of from 2022 as well as what they are most excited about in 2023.…
P
Pharmaceutical Executive

1 In Flux: The Sales & Marketing Outlook For 2023 31:15
31:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب31:15
As a society and industry, we’re emerging out of a period of hyper-accelerated digital and virtual growth, a positive born out of the COVID-19 pandemic. Many in the industry are wondering how the sales force is going to look and how they’re going to approach and communicate effectively with HCPs and patients. Pratap Khedkar, CEO of ZS, discusses this time of change with senior editor, Fran Pollaro, as well as the implications associated with the Inflation Reduction Act, the focus and importance of patient-centricity, what we might see in 2023 in the sales and marketing vertical, and more.…
P
Pharmaceutical Executive

1 The Gap In Mental Health Treatments: Schizophrenia 33:04
33:04
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:04
On this week’s episode, Meg Rivers, editor-in-chief, and Miranda Schmalfuhs, group social media editor, speak with Steve Paul, chairman of the board, president, and CEO of Karuna Therapeutics, as well as Andrew Miller, founder and chief operating officer of Karuna Therapeutics. Miller was also one of Pharm Exec’s 2020 Emerging Pharma Leaders. The editors speak with Paul and Miller about the following: 1) their journey into pharma; 2) the factors that impact their decision to pursue any individual drug product; 3) the mental health/disorder treatment landscape; 4) what treatment has been like, historically, for schizophrenia and psychosis in Alzheimer's disease; 5) the company’s drug, KarXT, which is being evaluated in schizophrenia and psychosis in Alzheimer's disease; and 6) potential marketing and commercialization challenges for KarXT.…
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.